Clinical outcomes | Intervention | Control | Model summaryb | |||||
---|---|---|---|---|---|---|---|---|
Baseline mean (SE) | Follow-up mean (SE) | Changea (SE) | Baseline mean (SE) | Follow-up mean (SE) | Changea (SE) | P valuec | ||
HbA1c | (%) | 8.4 (0.09) | 8.3 (0.09) | −0.1 (0.06) | 8.4 (0.09) | 8.5 (0.1) | 0.2 (0.07) | 0.003 |
(mmol/mol)d | 68.3 | 67.2 | −22.4 | 68.3 | 69.4 | −21.3 |  | |
Systolic BP (mmHg) | 139 (0.83) | 139 (0.86) | −0.3 (0.78) | 138 (0.81) | 140 (0.92) | 1.7 (0.75) | 0.08 | |
Diastolic BP (mmHg) | 80 (0.42) | 81 (0.44) | 0.4 (0.43) | 80 (0.44) | 82 (0.5) | 1.9 (0.47) | 0.02 | |
BMI (kg/m2) | 27.6 (0.23) | 27.8 (0.23) | 0.2 (0.08) | 28.5 (0.29) | 28.6 (0.27) | 0.1 (0.14) | 0.64 | |
WC (cm) | 95 (0.47) | 97 (0.56) | 2 (0.33) | 96 (0.56) | 97 (0.64) | 1.2 (0.37) | 0.08 | |
TC (mmol/L) | 5.3 (0.06) | 5.2 (0.05) | −0.1 (0.05) | 5.3 (0.05) | 5.2 (0.05) | −0.1 (0.05) | 0.90 | |
TG (mmol/L) | 2.2 (0.07) | 2.1 (0.05) | −0.1 (0.06) | 2 (0.06) | 2 (0.05) | −0.1 (0.05) | 0.64 | |
LDL-c ≤ 2.6 mmol/L | 3.2 (0.05) | 3.1 (0.05) | −0.02 (0.04) | 3.2 (0.05) | 3.1 (0.04) | −0.03 (0.04) | 0.84 | |
HDL-c ≥ 1.1 mmol/L | 1.1 (0.01) | 1.2 (0.01) | 0.02 (0.01) | 1.2 (0.02) | 1.3 (0.02) | 0.05 (0.02) | 0.09 |